SC 13G/A | 2017-04-07 | Rosalind Advisors, Inc. | Tonix Pharmaceuticals Holding Corp. | 594,077 | 9.9% | EDGAR |
SC 13G | 2017-04-07 | Empery Asset Management, LP | Tonix Pharmaceuticals Holding Corp. | 315,000 | 5.3% | EDGAR |
SC 13G/A | 2017-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Tonix Pharmaceuticals Holding Corp. | 696,455 | 1.8% | EDGAR |
SC 13G/A | 2017-02-14 | Flynn James E | Tonix Pharmaceuticals Holding Corp. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Tonix Pharmaceuticals Holding Corp. | 353,000 | 0.9% | EDGAR |
SC 13G/A | 2017-02-10 | CVI Investments, Inc. | Tonix Pharmaceuticals Holding Corp. | 1,177,500 | 2.9% | EDGAR |
SC 13G | 2016-11-30 | Rosalind Advisors, Inc. | Tonix Pharmaceuticals Holding Corp. | 2,220,055 | 5.7% | EDGAR |
SC 13G | 2016-11-04 | CVI Investments, Inc. | Tonix Pharmaceuticals Holding Corp. | 2,250,000 | 5.7% | EDGAR |
SC 13G/A | 2016-03-02 | Technology Partners Fund VIII LP | Tonix Pharmaceuticals Holding Corp. | 953,272 | 5.0% | EDGAR |
SC 13G/A | 2016-02-16 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Tonix Pharmaceuticals Holding Corp. | 1,467,858 | 7.8% | EDGAR |
SC 13G/A | 2016-02-16 | Flynn James E | Tonix Pharmaceuticals Holding Corp. | 1,315,551 | 7.0% | EDGAR |
SC 13G/A | 2016-02-12 | Broadfin Capital, LLC | Tonix Pharmaceuticals Holding Corp. | 1,243,748 | 6.5% | EDGAR |
SC 13G/A | 2016-02-10 | Technology Partners Fund VIII LP | Tonix Pharmaceuticals Holding Corp. | 681,306 | 3.6% | EDGAR |
SC 13G/A | 2015-03-12 | Technology Partners Fund VIII LP | Tonix Pharmaceuticals Holding Corp. | 681,306 | 6.3% | EDGAR |
SC 13G/A | 2015-02-17 | Broadfin Capital, LLC | Tonix Pharmaceuticals Holding Corp. | 501,639 | 4.7% | EDGAR |
SC 13G | 2015-02-17 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Tonix Pharmaceuticals Holding Corp. | 575,000 | 5.3% | EDGAR |
SC 13G | 2015-02-17 | Broadfin Capital, LLC | Tonix Pharmaceuticals Holding Corp. | 1,176,639 | 7.5% | EDGAR |
SC 13D/A | 2015-02-10 | LEDERMAN SETH | Tonix Pharmaceuticals Holding Corp. | 662,519 | 4.2% | EDGAR |
SC 13G | 2015-02-09 | Flynn James E | Tonix Pharmaceuticals Holding Corp. | 1,365,000 | 8.7% | EDGAR |
SC 13G/A | 2014-02-14 | Broadfin Capital, LLC | Tonix Pharmaceuticals Holding Corp. | 392,952 | 6.8% | EDGAR |